Repligen reported $52.66M in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agilent A:US USD 471M 60M
Align Technology ALGN:US USD 112.66M 30.99M
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bristol Myers Squibb BMY:US USD 1.94B 528M
Bruker BRKR:US USD 131.3M 57.4M
Catalent CTLT:US USD 60M 186M
Charles River Laboratories CRL:US USD 150.98M 36.43M
Danaher DHR:US USD 2.3B 281M
Dentsply International XRAY:US USD -1218000000 1.34B
Exact Sciences EXAS:US USD -138058000 21.53M
Fluidigm FLDM:US USD -29027000 9.54M
General Electric GE:US USD -72000000 268M
Henry Schein HSIC:US USD 211M 9M
Illumina ILMN:US USD -3657000000 3.08B
IQVIA Holdings Inc IQV:US USD 472M 19M
Mettler Toledo International MTD:US USD 275.88M 19.19M
Myriad Genetics MYGN:US USD -45000000 27.2M
Nanostring Technologies NSTG:US USD -34941000 2.15M
Orasure Technologies OSUR:US USD 875K 22.16M
Patterson Companies PDCO:US USD 60.1M 25.25M
Peregrine Pharmaceuticals PPHM:US USD -2684000 5.42M
Perkinelmer PKI:US USD 110.78M 140.08M
Pfizer PFE:US USD 5.17B 4.24B
Repligen RGEN:US USD 52.66M 10.5M
Thermo Fisher Scientific TMO:US USD 1.86B 151M
Waters WAT:US USD 192.01M 7.62M
West Pharmaceutical Services WST:US USD 136.6M 91.4M